Kliniske vurderinger af GONAL- f indikerer, at dens daglige dosis, administrationskuren og monitoreringsproceduren ikke skal være anderledes, end hvad der gælder for behandling med urin - baserede FSH- præparater.
Clinical assessment of GONAL-f indicates that its daily doses, regimens of administration, and treatment monitoring procedures should not be different from those currently used for urinary FSH-containing preparations.